Equities research analysts expect Motus GI Holdings (NASDAQ:MOTS) to post earnings per share (EPS) of ($0.26) for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Motus GI’s earnings. The lowest EPS estimate is ($0.27) and the highest is ($0.24). The business is expected to report its next quarterly earnings results on Tuesday, August 21st.
On average, analysts expect that Motus GI will report full-year earnings of ($1.09) per share for the current fiscal year, with EPS estimates ranging from ($1.12) to ($1.06). For the next fiscal year, analysts forecast that the firm will post earnings of ($0.90) per share, with EPS estimates ranging from ($0.91) to ($0.88). Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that cover Motus GI.
Several research analysts recently commented on the company. ValuEngine raised Motus GI from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. Oppenheimer started coverage on Motus GI in a report on Monday, March 12th. They set an “outperform” rating and a $7.00 price objective for the company. Finally, Piper Jaffray Companies started coverage on Motus GI in a report on Sunday, March 11th. They set an “overweight” rating and a $7.00 price objective for the company.
A hedge fund recently bought a new stake in Motus GI stock. Highbridge Capital Management LLC acquired a new stake in shares of Motus GI Holdings (NASDAQ:MOTS) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 200,000 shares of the company’s stock, valued at approximately $896,000. Highbridge Capital Management LLC owned 1.28% of Motus GI as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 22.38% of the company’s stock.
Motus GI traded up $0.15, hitting $4.70, during midday trading on Friday, Marketbeat reports. The stock had a trading volume of 13,100 shares, compared to its average volume of 59,539. The stock has a market cap of $72.71 million and a P/E ratio of -3.67. Motus GI has a 52 week low of $3.75 and a 52 week high of $7.85.
About Motus GI
Motus GI Holdings, Inc, a medical technology company, focuses on the development and commercialization of the Pure-Vu System. Its Pure-Vu System is designed to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.